Search

Your search keyword '"Asgary A"' showing total 58 results
58 results on '"Asgary A"'

Search Results

1. Management of primary molars with irreversible pulpitis employing tampon pulpotomy: Report of three cases with 34‐month mean follow‐up.

2. Apexogenesis of a symptomatic molar with calcium enriched mixture.

3. Effectiveness of pulpotomy compared with root canal treatment in managing non‐traumatic pulpitis associated with spontaneous pain: A systematic review and meta‐analysis.

4. A comparative study of dental pulp response to several pulpotomy agents.

5. Pulpotomy in caries-exposed immature permanent molars using calcium-enriched mixture cement or mineral trioxide aggregate: a randomized clinical trial.

6. The treatment of mature permanent teeth with irreversible pulpitis by cervical pulpotomy: A systematic review.

7. Comparison of pulp response to mineral trioxide aggregate and a bioceramic paste in partial pulpotomy of sound human premolars: a randomized controlled trial.

8. MTA pulpotomy of human permanent molars with irreversible pulpitis.

9. Success rate of permanent teeth pulpotomy using bioactive materials: A systematic review and meta‐analysis of randomized clinical trials.

10. Vital pulp therapy for permanent teeth with diagnosis of irreversible pulpitis: biological basis and outcome.

11. Outcome of partial and full pulpotomy in cariously exposed mature molars with symptoms indicative of irreversible pulpitis: A randomized controlled trial.

12. Evaluation of the outcome of apexogenesis in traumatised anterior and carious posterior teeth using mineral trioxide aggregate: a 5‐year retrospective study.

13. Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview - part I: vital pulp therapy.

14. Comment on methodological problems of 'Is there sufficient evidence to support the long-term efficacy of mineral trioxide aggregate for endodontic therapy in primary teeth?' by Anthonappa RP et al. ( International Endodontic Journal, 46, 198-204, 2013).

15. Influence of occlusal and proximal caries on the outcome of full pulpotomy in permanent mandibular molar teeth with partial irreversible pulpitis: A prospective study.

16. Conservative pulp therapy in the management of reversible and irreversible pulpitis.

17. Comparative efficacy of materials used in patients undergoing pulpotomy or direct pulp capping in carious teeth: A systematic review and meta‐analysis.

18. Effectiveness of vital pulp treatment in managing nontraumatic pulpitis associated with no or nonspontaneous pain: A systematic review.

19. Treatment outcome of partial pulpotomy using two different calcium silicate materials in mature permanent teeth with symptoms of irreversible pulpitis: A randomized clinical trial.

20. Mineral trioxide aggregate pulpotomy for permanent molars with clinical signs indicative of irreversible pulpitis: a preliminary study.

21. Immature permanent incisors with complicated crown fractures treated with partial pulpotomy using white mineral trioxide aggregate and IRoot BP plus‑a retrospective long‐term study.

22. Evaluation of the efficacy of mineral trioxide aggregate and bioceramic putty in primary molar pulpotomy with symptoms of irreversible pulpitis (a randomized‐controlled trial).

23. The effect of two different root canal sealers on treatment outcome and post‐obturation pain in single‐visit root canal treatment: A prospective randomized clinical trial.

24. Factors that influence the outcome of pulpotomy in permanent teeth.

25. A retrospective study of iRoot BP Plus pulpotomy compared with Vitapex pulpectomy for irreversible pulpitis of primary molars with the presence of coronal pulp tissue.

26. Outcomes reporting in systematic reviews on vital pulp treatment: A scoping review for the development of a core outcome set.

27. Present status and future directions—Vital pulp treatment and pulp preservation strategies.

28. Present status and future directions—Vital pulp treatment and pulp preservation strategies.

29. Comparative evaluation of complete and partial pulpotomy in mature permanent teeth with symptomatic irreversible pulpitis: A randomized clinical trial.

30. Outcome of full pulpotomy in mature permanent molars using 3 calcium silicate‐based materials: A parallel, double blind, randomized controlled trial.

31. Pulpotomy for treatment of complicated crown fractures in permanent teeth: A systematic review.

32. Association between concentration of active MMP‐9 in pulpal blood and pulpotomy outcome in permanent mature teeth with irreversible pulpitis – a preliminary study.

33. Scientometric analysis of vital pulp therapy studies.

34. The effect of partial pulpotomy with iRoot BP Plus in traumatized immature permanent teeth: A randomized prospective controlled trial.

35. Outcomes of direct pulp capping in vital primary teeth with cariously and non‐cariously exposed pulp: A systematic review.

36. A comparison of MTA and Biodentine as medicaments for pulpotomy in traumatized anterior immature permanent teeth: A randomized clinical trial.

38. European Society of Endodontology position statement: Management of deep caries and the exposed pulp.

39. Partial pulpotomy with two bioactive cements in permanent teeth of 6‐ to 18‐year‐old patients with signs and symptoms indicative of irreversible pulpitis: a noninferiority randomized controlled trial.

40. Biocompatibility and immunohistochemical evaluation of a new calcium silicate‐based cement, Bio‐C Pulpo.

41. Outcome of full pulpotomy using Biodentine in adult patients with symptoms indicative of irreversible pulpitis.

42. Assessment of alternative emergency treatments for symptomatic irreversible pulpitis: a randomized clinical trial.

43. Current trends and future perspectives of dental pulp capping materials: A systematic review.

44. Assessment of Mineral Trioxide Aggregate pulpotomy in mature permanent teeth with carious exposures.

45. Immunolocalization of dentin matrix protein-1 in human primary teeth treated with different pulp capping materials.

46. Clinical and radiographic outcomes of the use of Low-Level Laser Therapy in vital pulp of primary teeth.

47. Clinical and radiographic outcomes of the use of four dressing materials in pulpotomized primary molars: a randomized clinical trial with 2-year follow-up.

48. Is there sufficient evidence to support the long-term efficacy of mineral trioxide aggregate ( MTA) for endodontic therapy in primary teeth?

49. Second-generation platelet concentrate (PRF) as a pulpotomy medicament in a permanent molar with pulpitis: a case report.

50. Pulp preservation in immature permanent teeth.

Catalog

Books, media, physical & digital resources